Discrimination between the human prostate normal and cancer cell exometabolome by GC-MS-Reference-Cited by-同舟云学术

Discrimination between the human prostate normal and cancer cell exometabolome by GC-MS

Published:2018-04-03 Issue:1 Volume:8 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Lima Ana Rita,Araújo Ana Margarida,Pinto Joana^ORCID,Jerónimo Carmen^ORCID,Henrique Rui^ORCID,Bastos Maria de Lourdes,Carvalho Márcia^ORCID,Guedes de Pinho Paula^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/s41598-018-23847-9.pdf

Reference69 articles.

1. Kelly, R. S., Vander Heiden, M. G., Giovannucci, E. & Mucci, L. A. Metabolomic Biomarkers of Prostate Cancer: Prediction, Diagnosis, Progression, Prognosis, and Recurrence. Cancer Epidemiol Biomarkers Prev 25, 887–906, https://doi.org/10.1158/1055-9965.EPI-15-1223 (2016).

2. Siegel, R. L., Miller, K. D. & Jemal, A. Cancer Statistics. CA Cancer J Clin 67, 7–30, https://doi.org/10.3322/caac.21387 (2017).

3. Gaudreau, P. O., Stagg, J., Soulieres, D. & Saad, F. The Present and Future of Biomarkers in Prostate Cancer: Proteomics, Genomics, and Immunology Advancements. Biomark Cancer 8, 15–33, https://doi.org/10.4137/BIC.S31802 (2016).

4. Catalona, W. J. et al. Comparison of percent free PSA, PSA density, and age-specific PSA cutoffs for prostate cancer detection and staging. Urology 56, 255–260 (2000).

5. Catalona, W. J., Smith, D. S. & Ornstein, D. K. Prostate cancer detection in men with serum PSA concentrations of 2.6 to 4.0 ng/mL and benign prostate examination. Enhancement of specificity with free PSA measurements. JAMA 277, 1452–1455 (1997).

Cited by 57 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Precision detection of select human lung cancer biomarkers and cell lines using honeybee olfactory neural circuitry as a novel gas sensor;Biosensors and Bioelectronics;2024-10

2. Dual electro-/pH-responsive nanoparticle/hydrogel system for controlled delivery of anticancer peptide;Biomaterials Advances;2024-09

3. Identification of volatile biomarkers for lung cancer from different histological sources: A comprehensive study;Analytical Biochemistry;2024-07

4. Molecular landscape of THEDES selective toxicity towards colorectal cancer;2024-03-27

5. Urinary cancer detection by the target urine volatile organic compounds biosensor platform;Scientific Reports;2024-02-12